Medi-Caps
Ticker > Company >

Medi-Caps share price

Medi-Caps Ltd.

NSE: MEDICAPS BSE: 523144 SECTOR: Chemicals  23.18 K   79   10

39.25
-0.05 (-0.13%)
BSE: Today, 12:22 PM

Price Summary

Today's High

₹ 41.5

Today's Low

₹ 38

52 Week High

₹ 61

52 Week Low

₹ 37.1

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 48.94 Cr.

Enterprise Value

₹ 48.9 Cr.

No. of Shares

1.25 Cr.

P/E

100.31

P/B

0.73

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  53.69

CASH

₹ 0.05 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

50.77 %

EPS (TTM)

₹  0.39

Sales Growth

6966.47%

ROE

6.09 %

ROCE

7.57%

Profit Growth

1411.74 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year6966.47%
3 Year∞%
5 Year-19.82%

Profit Growth

1 Year2554.06%
3 Year233.5%
5 Year45.75%

ROE%

1 Year6.09%
3 Year2.13%
5 Year-1.34%

ROCE %

1 Year7.57%
3 Year2.64%
5 Year-1.02%

Debt/Equity

0

Price to Cash Flow

15.82

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 50.77 0.00
Mar 2025 50.77 0.00
Dec 2024 50.62 0.00
Sep 2024 50.43 0.00
Jun 2024 50.13 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • Company’s PEG ratio is 0.0710693605529863.
  • The company has an efficient Cash Conversion Cycle of 24.9764 days.
  • Company has a healthy liquidity position with current ratio of 18.6336.
  • The company has a high promoter holding of 50.77%.

 Limitations

  • Company has a poor ROE of 2.13059351994008% over the past 3 years.
  • Company has a poor ROCE of 2.63623197616607% over the past 3 years
  • The company has a low EBITDA margin of -58.3724033404672% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 129.0485.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 0.29 0.98 0.26 0.89 0
Total Expenditure 0.69 0.59 0.58 0.68 0.67
Operating Profit -0.4 0.39 -0.31 0.21 -0.67
Other Income 0.11 0.1 0.09 0.27 0.31
Interest 0 0 0 0 0
Depreciation 0.04 0.04 0.04 0.04 0.04
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.33 0.45 -0.27 0.44 -0.4
Tax 0 0 0 -0.27 0
Profit After Tax -0.33 0.45 -0.27 0.71 -0.4
Adjusted EPS (Rs) -0.27 0.36 -0.21 0.57 -0.32

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 10.91 0 0 0.1 7.17
Total Expenditure 19.98 0 0.56 0.39 2.33
Operating Profit -9.07 0 -0.56 -0.29 4.84
Other Income 1.12 0 0.61 0.64 0.15
Interest 0.01 0 0.01 0 0
Depreciation 0.36 0 0.09 0.09 0.16
Exceptional Items 0 0 0 0 0
Profit Before Tax -8.32 0 -0.06 0.26 4.83
Tax 0.01 -0.01 0.01 0 0.94
Net Profit -8.33 -0.11 -0.04 0.15 3.89
Adjusted EPS (Rs.) -6.68 0 -0.06 0.21 3.12

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 12.47 12.47 12.47 12.47 12.47
Total Reserves 47.38 48.5 48.82 48.64 54.02
Borrowings 0 0 0 0 0
Other N/C liabilities 0.68 0.56 0.44 0.44 0.43
Current liabilities 1.03 1.11 0.08 0.08 1.17
Total Liabilities 61.55 62.64 61.81 61.63 68.09
Assets
Net Block 3.63 3.26 2.78 2.46 2.26
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 45.47 43.02 43.91 43.91 43.91
Loans & Advances 0.05 0.05 0.05 0.05 0.05
Other N/C Assets 0 1.08 0 0 0
Current Assets 12.4 15.23 15.07 15.2 21.88
Total Assets 61.55 62.64 61.81 61.63 68.09
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -8.32 -0.12 -0.06 0.26 4.83
Adjustment 0.94 1.57 0.58 -0.28 1.65
Changes in Assets & Liabilities 6.45 0.79 -1.47 -2.57 -2.44
Tax Paid 0 0 0 0 -0.95
Operating Cash Flow -0.92 2.24 -0.95 -2.6 3.09
Investing Cash Flow -0.4 -2.19 1.01 1.85 -3.09
Financing Cash Flow -0.06 -0.06 0 0 0
Net Cash Flow -1.38 -0.02 0.06 -0.75 0

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 50.13 50.43 50.62 50.77 50.77
akshit garg - 0.14 0.26 0.31 0.31
alok k garg 25.87 25.87 25.87 25.87 25.87
kusum mittal 0.08 0.10 0.10 0.10 0.10
manisha garg 21.61 21.61 21.61 21.61 21.61
nirmala mittal - 0.03 0.03 0.03 0.03
palash garg - 0.14 0.21 0.31 0.31
ramesh chandra mittal 0.08 0.08 0.08 0.08 0.08
trapti investments llp 2.46 2.46 2.46 2.46 2.46
nirmala mittal 0.03 - - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 49.87 49.57 49.38 49.23 49.23
dheeraj kumar lohia 4.22 4.79 4.75 4.69 4.69
investor education and pr... - - 0.65 0.65 0.65
manju gaggar - - - 1.02 1.02
sangeetha s 5.57 5.57 5.57 5.57 5.55
sonal lohia 1.40 1.43 1.43 1.43 1.44
investor education and pr... 0.65 0.65 - - -

Annual Reports

Title Link
Title Link
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

 No Latest News available for this company.Report us

Medi-Caps Stock Price Analysis and Quick Research Report. Is Medi-Caps an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Medi-Caps. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Medi-Caps has a PE ratio of 100.306670074112 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Medi-Caps has ROA of 5.9949% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Medi-Caps has a Current ratio of 18.6336.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Medi-Caps has a ROE of 6.0945%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Medi-Caps has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Medi-Caps has reported revenue growth of 6966.4694% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Medi-Caps for the current financial year is 67.5510090155469%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Medi-Caps is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Medi-Caps is Rs 0.3913. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Medi-Caps in Ticker for free. Also, one can get the intrinsic value of Medi-Caps by using Valuation Calculators, which are available with a Finology ONE subscription. 

Medi-Caps FAQs

Q1. What is Medi-Caps share price today?
Ans: The current share price of Medi-Caps is Rs 39.25.

Q2. What is the market capitalisation of Medi-Caps?
Ans: Medi-Caps has a market capitalisation of Rs 48.9445773 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Medi-Caps?
Ans: The PE ratio of Medi-Caps is 100.306670074112 and the P/B ratio of Medi-Caps is 0.731105804514415, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Medi-Caps share?
Ans: The 52-week high share price of Medi-Caps is Rs 61, and the 52-week low share price of Medi-Caps is Rs 37.1.

Q5. Does Medi-Caps pay dividends?
Ans: Currently, Medi-Caps does not pay dividends. Dividend yield of Medi-Caps is around 0%.

Q6. What are the face value and book value of Medi-Caps shares?
Ans: The face value of Medi-Caps shares is Rs 10, while the book value per share of Medi-Caps is around Rs 53.6858. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Medi-Caps?
Ans: Medi-Caps has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Medi-Caps?
Ans: The ROE of Medi-Caps is 6.0945% and ROCE of Medi-Caps is 7.5666%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Medi-Caps a good buy for the long term?
Ans: The Medi-Caps long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Medi-Caps undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Medi-Caps appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Medi-Caps’s financials?
Ans: You can review Medi-Caps’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Medi-Caps
X